Non-disclosure of clinical trial results sees drug firms censured
A new study published in the British Medical Journal (BMJ) has found that many pharmaceutical companies are still far from transparent
When your doctor advises you to take a certain medicine, you might assume he or she has been able to scrutinise the effectiveness and safety of that medicine based on clinical trials carried out. That’s not necessarily the case.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events
- Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
- Access to The Business Post's extensive archive
